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Physical removal of mammalian cumulus-oocyte complexes (COCs) from ovarian 
follicles results in spontaneous resumption of meiosis, largely due to a decrease in cAMP 
concentrations, causing asynchrony between cytoplasmic and nuclear maturation and 
decreased oocyte developmental competence. The aim of this study was to modulate 
cAMP concentrations within ovine COCs to delay spontaneous nuclear maturation and 
improve developmental competence. Abattoir-derived sheep COCs were cultured for 2 h 
(pre-IVM) in 100 µM forskolin (FSK) plus 500 µM 3-isobutyl-1-methylxanthine (IBMX). 
Pre-IVM (100 µM FSK and 500 µM IBMX) culture increased COC cAMP concentrations 
10-fold compared to controls (P<0.05). With regards to nuclear maturation, 
+FSK+IBMX/+FSH+cilostamide delayed completion of meiosis (metaphase II, MII) by 3 
to 4 h compared to standard IVM (FSH-stimulated induction of meiosis). In this study, 
pre-IVM (+FSK+IBMX) followed by IVM (+FSH+cilostamide), increased ovine COC cAMP 
concentrations and delayed, but did not inhibit, completion of nuclear maturation. This 
did not affect embryo development rates, but increased total cell number of blastocysts 
compared to IVM with FSH alone (103+6 vs 66+4 cells, respectively, mean ± SEM; 
P<0.05). We inferred that regulation of ovine oocyte cAMP concentrations during IVM 
improved embryo quality compared to embryos produced by standard IVM methods. 
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There is accumulating evidence that modulation of cAMP during oocyte in vitro 
maturation (IVM) may be a solution to the current discrepancy in developmental 
competence between oocytes produced by IVM and those matured in-vivo [1]. It is well 
established that intra-oocyte cyclic adenosine monophosphate (cAMP) has a major role 
in regulating mammalian oocyte maturation. A high intra-oocyte cAMP concentration is 
produced endogenously within the oocyte by adenylate cyclases and constitutively 
active G-protein-coupled receptors (GPR) [2] and is generated by cumulus cells (CC) 
and transported to the oocyte via gap junctions [3,4]. Cyclic guanosine monophosphate 
(cGMP) diffuses from granulosa cells to the oocyte and inhibits cAMP degradation by 
inhibiting PDE3A [5,6]. In rodents, elevated cAMP concentrations activate protein 
kinase-A (PKA), followed by complex inhibitory mechanisms involving CDK1 –cyclin B 
kinase proteins suppressing activation of maturation promoting factor (MPF) and 
preventing meiosis [7-9]. In vivo, the pre-ovulatory surge of LH decreases cGMP 
concentrations in granulosa cells as well as oocytes [5,6]; the subsequent activation of 
PDE3A resulted in degradation of cAMP, activation of MPF, and resumption of meiosis 
(review; Conti et. al. [7]). The downstream pathways through which cAMP effects 
meiosis are not fully characterised in larger mammals like cattle [10] or sheep. 
However, there are major differences among species with regards to cAMP degrading 
phosphodiesterase (PDE) isoforms [11,12]. Maintenance of cAMP concentrations within 
an oocyte is achieved through a balance of production (synthesis of cAMP with 
adenylate cyclases and GPR), degradation (mainly the result of PDEs), and cAMP 
transfer from CCs.  
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Discrepancies between IVM and in-vivo matured oocytes in embryo yield and 
pregnancy outcomes have been reported consistently across mammalian species [13-
16]. The ovine oocyte is no different in this respect, with one report citing blastocyst 
rates of 35 and 75% for in vitro- and in vivo-matured oocytes, respectively [16]. When 
the oocyte is mechanically removed from the follicular environment, meiotic 
resumption occurs spontaneously [17]. This spontaneous resumption of meiosis is 
accompanied by a rapid decrease in oocyte cAMP and is associated with reduced 
developmental competence [18]. There is now ample evidence that culturing oocytes in 
an environment where meiosis is regulated (via cAMP management), either prior to or 
during IVM, improves developmental competence [19-23]. This can be achieved by 
preventing the decrease in cAMP concentrations using PDE inhibitors throughout IVM, 
or by increasing COC cAMP concentrations during maturation with cAMP-elevating 
agents, e.g. cAMP analogues, adenylate cyclase activators, or PDE inhibitors (reviewed 
[24]). 
Our laboratory recently developed a cAMP-based modulating IVM system for 
mice and cattle; Simulated Physiological Oocyte Maturation (SPOM) [13] aims to 
improve developmental competence by attenuating oocyte spontaneous nuclear 
maturation upon liberating an oocyte from the follicle [25]. This is achieved by 
increasing cAMP concentrations using cAMP modulating compounds over two intervals: 
during pre-IVM to generate high COC cAMP concentrations, followed by an induced IVM 
phase, where re-initiation of meiosis is driven by follicle stimulating hormone (FSH) in 
the presence of an oocyte-specific PDE inhibitor. The premise of the SPOM system is to 
delay nuclear maturation by increasing cAMP concentrations in the oocyte, providing a 
regulated transition of the meiotic stages and more time for oocyte-cumulus cell gap 
junction communication (GJC), and prolonging the exchange of positive regulatory 
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molecules and metabolites for improved oocyte cytoplasmic maturation. High cAMP 
concentrations are generated by addition of an adenylate cyclase activator and 
maintained by addition of PDE inhibitors (specific and non-specific). 
The objective of the present study was to apply the principles of the SPOM 
system to improve developmental competence of ovine oocytes. Cumulus-oocyte 
complexes were recovered from peripubertal sheep (6-12 mo), which enabled 
assessment of the effectiveness of SPOM in oocytes with inherently reduced 
developmental competence. It is well established that oocytes from prepubertal 
domestic species have reduced rates of development and poorer embryo quality 
[26,27]. Nonetheless, Juvenile In Vitro Embryo Transfer (JIVET), namely the in vitro 
production and subsequent transfer of embryos from prepubertal animals, is a highly 
attractive means of rapidly multiplying elite animals for genetic improvement [27,28]. 
As with cattle, exploitation of superior ovine genetics is desirable, but is currently 
limited due to the poor cost-benefit ratio. Therefore, any advancement in enabling 
technologies that benefit seed-stock producers would be desirable. In particular, the 
benefit in developing effective breeding strategies from immature ewe-lambs would 
enhance the feasibility of applying this technology.  
 
2. Materials and methods 
 
Unless otherwise specified, all chemicals used in the following protocols were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA). 
 




Ovaries from peripubertal sheep (approximately 6 to 12 mo old), were obtained 
from an abattoir and transported in warm (29 to 32 °C) saline within 3 to 4 h after 
slaughter. Antral follicles > 3 mm in diameter were aspirated using a 20-gauge needle 
and constant suction (1 L/min) into vacutainer tubes containing 2.5 mL of aspiration 
medium (VitroCollect V1, IVF Vet Solutions, Adelaide, Australia; + 0.2 mg/mL BSA, 
ICPbio Ltd, Auckland, New Zealand; + 500 μM 3-Isobutyl-1-methylxanthine (IBMX, a 
non-specific PDE inhibitor) + 50 mIU/mL heparin). Within 15 min after aspiration, the 
cellular sediment was transferred into collection media (see experimental design). The 
COCs with more than three cumulus cell layers and a uniform ooplasm were washed 
once in collection medium and once in corresponding maturation medium. The base 
maturation medium was VitroMat V1 (IVF Vet Solutions) + 4 mg/mL low fatty acid BSA 
+ 100 mIU/mL recombinant human FSH (Puregon, Organon, Oss, Netherlands). Groups 
of up to 10 COCs were transferred into pre-equilibrated 100 μL drops of maturation 
medium overlaid with mineral oil and incubated at 38.5 °C with 6% CO2 humidified air. 
Pre-IVM culture occurred at -2 to 0 h (0 h was the onset of IVM culture). 
 
2.2. Oocyte meiotic assessment 
 
At the end of defined periods of oocyte maturation, COCs were mechanically 
denuded by repeated pipetting and then fixed by placement in 4% paraformaldehyde 
for > 30 min at 4 °C. Thereafter, fixed oocytes were incubated in permeabalization 
solution (0.5% triton 100X and 0.5% sodium citrate) for 15 to 30 min, followed by 
incubation in 3 μM 4',6-diamidino-2-phenylindole (DAPI) solution in the dark for 15 
min. Oocytes were washed in 0.01% (w/v) BSA in PBS, and mounted on a slide with 
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glycerol and antifade (Prolong, Invitrogen, Carlsbad, CA, USA) in a 3:1 ratio. 
Chromosome configurations were assessed using a Nikon Eclipse TE2000-E Microscope 
(330 to 380 nm excitation wavelength. Nikon, Melville, NY, USA).  
 
2.3. cAMP assay 
 
Concentrations of cAMP were measured with a validated radioimmunoassay 
[29]. Groups of 10 COCs were collected in minimal media, snap frozen in liquid N2, and 
stored at -80 °C. Prior to quantification, 0.5 mL of cold 100% ethanol was added to the 
COCs, vortexed and stored at -20°C overnight. Samples were centrifuged at 3,000 g for 
15 min at 4 °C, air dried and re-suspended in assay buffer (0.05 M sodium acetate, pH 
6.2) and acetylated in triethylamine:acetic anhydride solution (2:1 ratio). The cAMP 
antibody and 125I-cAMP tracer were added to samples and incubated overnight at 4 °C. 
Cold ethanol was added to samples and centrifuged at 3000 g for 10 min at 4 °C. 
Supernatant was discarded, samples were air dried, and cAMP quantified using a 
gamma counter. Samples were measured in duplicates and compared to a standard 
curve of known cAMP concentration (1024 to 0 fmol cAMP). Intra- and inter-assay CVs 
were 7.1 and 10.4%, respectively. 
 
2.4. Experimental design 
 





A cilostamide dose response experiment was performed to determine the 
optimal concentration of the PDE3 specific inhibitor to delay nuclear maturation during 
the IVM phase. Treatments included control (VitroMat + 4 mg/mL BSA + 100 mIU/mL 
FSH) 0.1, 1, 10, and 100 μM cilostamide (Enzo Life Sciences, Farmingdale, NY, USA). The 
COCs were removed at 24 h, denuded, and nuclear maturation was assessed using DAPI 
chromatin staining. The experiment consisted of four replicates (average of 20 oocytes 
per treatment). 
 
2.4.2. Experiment 2. Effect of FSK and IBMX supplementation on COC cAMP 
concentrations after pre-IVM 
 
The effect of cAMP modulators during pre-IVM treatment on cAMP 
concentrations at the end of pre-IVM was determined. Aspirate sediment (2 mL) was 
randomly allocated to 10 mL of: 1) control = VitroCollect + 0.2 mg/mL BSA; 2) control + 
50 μM FSK; 3) control + 100 μM FSK; 4) control + 500 μM IBMX; 5) control + 500 μM 
IBMX + 50 μM FSK; and 6) control + 500 μM IBMX + 100 μM FSK. Groups of 10 COCs 
were collected at the end of the 1.5 to 2 h pre-IVM phase, washed twice, and snap frozen 
in liquid N2 for cAMP radioimmunoassay. The experiment consisted of three replicates 
with 10 COCs per treatment, per replicate. 
 
2.4.3. Experiment 3. Effect of pre-IVM treatment and cilostamide during IVM on in 
vitro nuclear maturation 
 
This experiment was conducted to determine the optimal concentration of 
cilostamide during IVM when combined with a pre-IVM treatment. Aspirate sediment (2 
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mL) was randomly allocated to 10 mL: 1) control = VitroCollect + 0.2 mg/mL BSA, or 2) 
pre-IVM = control + 500 μM IBMX + 50 μM FSK and incubated at 38.5 °C for 1.5 to 2 h. 
After the pre-IVM phase, COCs were transferred to IVM culture media: A) control = 
VitroMat + 4mg/mL BSA + 100 mIU/mL FSH; B) control + 1 μM cilostamide; or C) 
control + 20 μM cilostamide. The COCs were removed at 20 h, denuded and nuclear 
maturation assessed using DAPI chromatin staining. The experiment consisted of four 
replicates, each averaging 22 oocytes per treatment. 
 
2.4.4. Experiment 4. Effect of pre-IVM and IVM conditions on COC cAMP 
concentrations after IVM 
 
The effects of cAMP modulating agents on COC cAMP concentrations after IVM 
were determined. Aspirate sediment (2 mL) was randomly allocated to 10 mL: 1) 
control = VitroCollect + 0.2 mg/mL BSA, or 2) pre-IVM = control + 500 μM IBMX + 100 
μM FSK and incubated at 38.5 °C for 1.5 to 2 h. After the pre-IVM phase, COCs were 
transferred to IVM culture media: A) control = VitroMat + 4 mg/mL BSA; B) control + 
100 mIU/mL FSH; C) control + 1 μM cilostamide; or D) control + 100 mIU/mL FSH + 1 
μM cilostamide. Groups of 10 COCs were collected at 20 h IVM and snap frozen in liquid 
N2 for the cAMP radioimmunoassay. The experiment consisted of two replicates with 10 
COCs per treatment, per replicate. 
 
2.4.5. Experiment 5. Effect of SPOM on meiotic progression to MII 
 
Based on the results of the previous four experiments, an ovine-adapted SPOM 
system was defined as: pre-IVM (VitroCollect containing 0.2 mg/mL BSA + 500 μM 
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IBMX + 100 μM FSK) followed by IVM (VitroMat containing 4 mg/mL BSA + 100 
mIU/mL FSH + 1 μM cilostamide). To assess the effects of SPOM on the kinetics of 
meiotic progression, COCs were randomly allocated to: 1) control (Standard IVM); 
collection in VitroCollect + 0.2 mg/mL BSA followed by IVM in VitroMat + 4 mg/mL BSA 
+ 100 mIU/mL FSH; or 2) SPOM (as defined above). Approximately 20 COCs were 
collected at 21, 24, 27 and 30 h; denuded and nuclear maturation was assessed using 
DAPI chromatin staining. The experiment consisted of five replicates, with each 
replicate averaging 20 oocytes per treatment. 
 
2.4.6. Experiment 6. Effect of SPOM on oocyte developmental competence 
 
To assess the effects of ovine-SPOM on oocyte developmental competence, 
oocytes were fertilized after 24 h (control) or 27 h (SPOM) of maturation. Thereafter, 
cleavage and blastocyst rates and blastocyst cell numbers were determined. After 
oocyte maturation (Day 0), excess CC were removed by gentle pipetting (corona radiata 
remained intact) in 400 IU/mL hyaluronidase, washed twice in IVF medium (as 
described [30]), and 25 to 30 COCs were transferred into 450 μL of pre-equilibrated IVF 
medium overlaid with oil. Motile sperm were obtained using a “swim-up” method; 150 
μL of frozen-thawed sperm, pooled from two rams of proven fertility, were placed 
under 1 mL of IVF medium in a 14-mL tube. Motile sperm were retrieved from the 
upper portion after 30 to 60 min, approximately 1x106 sperm/mL was then added to 
the COCs, which were incubated at 38.5 °C in humidified 5% CO2 air. 
After 24 h, remaining CC were removed by gentle pipetting, presumptive zygotes 
were washed three times in in vitro culture (IVC) media [30] and 25 to 30 presumptive 
zygotes were cultured in 600 μL of IVC medium overlaid with oil at 38.5 °C in 
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humidified 5% CO2, 5% O2, and 90% N2 air. Non-cleaved oocytes were removed on Day 
1 and cleavage was recorded. Embryo development was subsequently assessed on Day 
7. The experiment consisted of five replicates, each averaging ~70 oocytes per 
treatment. To assess the effects of SPOM on blastocyst cell numbers, in three of the five 
replicate experiments, Day-7 blastocysts were mounted on a slide in drops of Hoechst, 
and incubated overnight at 4 °C. Embryo cell number was counted using a Nikon Eclipse 
TE2000-E Microscope (excitation wavelength = 330 to 380 nm). 
 
2.5. Statistical analyses 
 
All experimental data were analysed using the SPSS Statistics Program (PASW 
Stats V.17, SSPSS Inc., Chicago, IL, USA). One way ANOVA (Experiments 1 and 5) with 
post-hoc Bonferroni comparison and nonparametric analysis (Experiment 5 – total cell 
number) were used to determine significance (Experiments 1 to 5). For all analyses, P < 




3.1. Experiment 1. Effect of the type-3 PDE inhibitor (cilostamide) on nuclear 
maturation 
 
A cilostamide dose-response experiment was conducted to determine its effect 
during IVM on nuclear maturation. Cilostamide supplementation attenuated the 
spontaneous resumption of meiosis by COCs in a dose-dependent manner following 24 
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h incubation (P < 0.001, Fig. 1). The presence of 1 µM cilostamide reduced (P < 0.05) the 
proportion of oocytes completing nuclear maturation, and at 100 µM, 3.5-fold less COCs 
reached MII (compared to COCs cultured in the absence of cilostamide).  
 
3.2. Experiment 2. Effect of FSK and IBMX supplementation on COC cAMP 
concentrations after pre-IVM 
 
The effect of adding IBMX and FSK to a pre-IVM treatment on initial COC cAMP 
concentrations after 2 h of culture was assessed. The COCs cultured in the absence of 
cAMP modulators had lower cAMP concentrations, compared to other treatment groups 
(Fig. 2). There was no significant difference between cAMP concentrations in COCs 
treated with 50 versus 100 μM FSK. The presence of 500 μM IBMX with 100 μM FSK 
resulted in a 10-fold increase in cAMP concentrations (176 ± 33 fmol/COC) compared to 
the control group (17 ± 15 fmol/COC, P < 0.05, Fig. 2). 
 
3.3. Experiment 3. Effect of pre-IVM treatment and cilostamide supplementation 
during IVM on in vitro nuclear maturation 
 
The effect of treating COCs with FSK (an adenylate cyclase activator) and IBMX (a 
non-specific PDE inhibitor) during a pre-IVM phase followed by IVM culture with 
various concentrations of cilostamide on nuclear maturation status after 20 h 
maturation was assessed. Cilostamide at 20 μM (without pre-IVM) compared to pre-IVM 
only (-cilostamide) had more oocytes at MI (P <0.05). There were no significant 
differences between treatments in anaphase I and teleophase I stages. However, the 
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combination of 20 μM cilostamide supplementation during IVM and pre-IVM culture, 
tended to reduce oocytes at MII, with approximately 3-fold less reaching MII compared 
to control (P = 0.081, Fig. 3).  
 
3.4. Experiment 4. Effect of pre-IVM and IVM conditions on COC cAMP 
concentrations after IVM 
 
The effect of pre-IVM treatment and FSH and cilostamide supplementation 
during the IVM phase, on COC cAMP concentrations after 20 h of IVM was assessed 
using a multi-factorial experimental design. The COCs within the control group, with no 
cAMP modulators (- pre-IVM, - FSH, - cilostamide), had cAMP concentrations of 0.33 ± 
0.04 fmol/COC, whilst standard IVM conditions (- pre-IVM, + FSH, - cilostamide) yielded 
COCs with 1.00 ± 0.24 fmol/COC (Fig. 4). The combined components of the SPOM 
system had the highest COC cAMP concentrations of all treatments (Fig. 4). 
 
3.5. Experiment 5. Effect of ovine-adapted SPOM on meiotic progression to MII 
 
The extent of delay in completing nuclear maturation in oocytes cultured in an 
ovine-adapted SPOM system (pre-IVM with 500 μM IBMX + 50 μM FSK and IVM with 
100 mIU/mL FSH + 1 μM cilostamide) compared to IVM conducted with 100 mIU/mL 
FSH, with no pre-IVM treatment was assessed. In standard IVM (+ FSH), 77.9 ± 1.3 % of 
COCs reached the MII stage by 21 h of maturation, compared to 54.1 ± 8.3 % of COCs 
cultured in the SPOM system (P = 0.001, Fig. 5). By 27 h, SPOM oocytes reached 
approximately the same rates of MII as standard IVM at 24 h (the standard insemination 
time for ovine IVM). All COCs cultured in the IVM (with FSH) and SPOM systems reached 
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MII by 30 h of culture, indicating no prevention of maturation in either culture system 
(Fig. 5). Based on these data, we inferred that the optimal, comparable time for 
insemination of SPOM oocytes was 27 to 28 h post-maturation.  
 
3.6. Experiment 6. Effect of ovine-adapted SPOM on oocyte developmental 
competence 
 
The developmental competence of COCs cultured in SPOM versus standard IVM 
(with FSH) was determined by comparing cleavage rates, on-time embryo development 
on Day 7 and blastocyst cell numbers, following IVF and IVC. There was no significant 
difference in cleavage rates between treatments, with approximately 79% of oocytes 
successfully cleaving in both treatments (Table 1). On Day 7 of culture, approximately 
54% of all cleaved zygotes developed into blastocysts in both standard IVM and SPOM 
treatments, with no significant differences in blastocyst yield. However, SPOM 
blastocysts had substantially more cells (1.6-fold) per embryo compared to standard 




In-vivo, the surge of gonadotrophins prior to ovulation overrides natural meiotic 
inhibition and specific epidermal growth factor (EGF)-like peptides initiate cascades 
that induce oocyte maturation [31]. In comparison, mechanical removal of the oocyte 
from the follicular environment results in spontaneous resumption of meiosis [17]. In 
this study, we investigated the effect of using modulators of cAMP to control meiotic 
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maturation within ovine oocytes from 6 to 12 mo-old lambs (a less-competent oocyte 
model), utilizing a new approach to cAMP-regulated meiosis (SPOM). Similar to that 
reported for the murine and bovine COC [13], in an ovine-adapted SPOM model, the aim 
was to increase cAMP concentrations within the COC at the time of collection from the 
follicle, thereby preventing spontaneous meiotic resumption (pre-IVM). This initial 
increase in COC cAMP concentrations was followed by inhibition of PDE-mediated cAMP 
degradation using a type-3 specific PDE inhibitor and FSH-stimulated induction of 
meiosis during an extended IVM phase [1] . 
Oocyte developmental competence is compromised in spontaneous IVM due to 
many factors, including presumably an absence of the full ovulatory molecular EGF 
cascade in CC and premature breakdown of oocyte-cumulus cell gap junctions; together 
this reduced exchange of positive regulatory molecules and metabolites from the 
follicular compartment [32]. Furthermore, meiotic resumption occurs in a rapid and 
uncontrolled manner [25]. However, the SPOM and related IVM models using elevated 
cAMP concentrations attenuated spontaneous meiosis, thereby resulting in a more 
gradual cessation of oocyte transcription and transition into the M-phase and 
promoting and prolonging oocyte-cumulus cell gap junction communication (GJC) 
[13,32-35].  Part of the rationale for these approaches were substantial increases in 
cAMP occurred in vivo following LH-induction of the ovulatory cascade in porcine [36] 
and murine COCs [13,37]. In contrast, liberation of the oocyte from the follicle for 
spontaneous IVM drastically decreases COC cAMP [13,34,38]. In the current study, the 
1.5 to 2 h pre-IVM treatment with cAMP modulators, FSK and IBMX in the SPOM system, 
resulted in a > 10-fold increase in COC cAMP concentrations compared to COCs exposed 
to pre-IVM conditions in the absence of FSK and IBMX. Comparatively, SPOM pre-IVM in 
bovine generated a 100-fold increase in cAMP concentrations [13]. Apparent differences 
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between the two species may be due to the presence and expression of different PDE 
and adenylate cyclase isoforms [11]. However, since cAMP concentrations do not 
substantially differ between ovine and bovine COCs in the presence of IBMX and FSK (< 
20 fmol/COC), perhaps peripubertal ovine COCs have greater endogenous production of 
cAMP, or ovine PDEs degrade cAMP at a slower rate than in bovine COCs. Nonetheless, 
IBMX and FSK together generated high COC cAMP concentrations (compared to the 
absence of cAMP modulators).  
The pre-IVM phase in the SPOM system primarily targets CC to increase cAMP 
concentrations in CC and also serves to maintain CC-oocyte GJC [13,32]. These two 
effects combine to load the oocyte with cAMP from the CC [39]. In parallel, increases in 
CC cAMP induce expression of EGF-like peptides and subsequent activation of the EGF 
receptor and MAPK pathway, thereby stimulating cumulus expansion and oocyte 
maturation [40-42]. It is widely reported that cAMP modulators in cattle IVM extended 
CC-oocyte GJC and increased oocyte developmental competence [13,19,20,32,43,44]. 
Therefore, the ovine SPOM system increases COC cAMP concentrations, preventing the 
spontaneous resumption of meiosis, likely by maintaining GJC between the oocyte and 
cumulus cells and maintaining higher cAMP concentrations in cumulus cells and 
oocytes. 
In previous studies, PDE inhibitors have been used extensively in various 
experimental IVM systems in an effort to improve oocyte developmental competence 
[45]. However, they have apparently not yet been examined in ovine IVM. In the current 
study, 1 μM cilostamide delayed completion of nuclear maturation by 30% compared to 
the control. Furthermore, the full ovine-SPOM system delayed completion of meiosis by 
3 to 4 h. Concentrations of PDE inhibitors used in the ovine-SPOM system differed from 
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those used in the bovine and murine SPOM models [13]. For example, during IVM, 
optimal cilostamide concentrations were 1 μM (sheep, current study) 20 μM (cattle) and 
0.1 μM (mouse) [13]. This was expected due to differences among species in PDE 
kinetics, the presence of other PDE subtypes within the oocyte, and varying 
concentrations of endogenous oocyte cAMP production [46]. In the pre-IVM phase, 10-
fold higher concentrations of IBMX were needed in bovine compared to murine models 
(500 versus 50 μM, respectively), perhaps due to expression of PDE8 in bovine COCs, 
which accounted for more than 20% of total PDE activity and is not inhibited by IBMX 
[11]. Conversely, murine cumulus cells did not express PDE8, but expressed the IBMX-
sensitive PDE4 as its major cumulus cell PDE [12]. Hence, lower concentrations of IBMX 
are required during the murine pre-IVM phase, compared to the bovine system. 
Expression of different PDEs within ovine cumulus cells and oocytes are unknown and 
requires further investigation.  
The combined actions of cAMP modulators in pre-IVM and during the IVM phase 
prevented degradation of COC cAMP, and at the end of IVM, SPOM had the highest cAMP 
concentration out of all experimental groups. The meiotic inducing effects of FSH 
present in IVM allowed the attenuated meiosis to continue with an approximate delay of 
3 to 4 h. However, the sheep SPOM system did not cause notable increases in blastocyst 
and cleavage rates previously reported in cattle and mice [13]. There is currently no 
clear explanation for this difference, but it could be the result of the age of the sheep 
used. Nonetheless, in the current study, the SPOM IVM system significantly increased 
total cell number of blastocysts, which has been reported to reflect developmental 
competence, as shown by increased capacity to develop into a viable fetus following 
transfer to donors, regardless of blastocyst formation and hatching rates [47].  
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Based on this study, in combination with other working SPOM models [13], we 
inferred that use of SPOM improved outcomes from IVM. Hence, SPOM may have an 
application in domestic animal artificial breeding programs, where there is a need to 
improve the efficiency of in vitro embryo production methodologies. Since it is widely 
recognized that the IVM phase is rate-limiting, particularly when COCs from juvenile 
animals are used to produce embryos in vitro (JIVET), the SPOM system described 
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Table 1: Comparison (means ± SEM) of Standard-IVM to SPOM on development of ovine  
embryos. 
Treatment Cleaved (%) 
Blastocyst/cleaved (%) 
Total no. cells 
Total Expanded Hatched 
Standard- IVM 78.7 ± 3.1 54.2 ± 2.3 38.1 ± 4.2 14.5 ± 3.2 63.5 ± 3.9a 
SPOM 79.4 ± 2.2 53.5 ± 3.2 36.8 ± 5.9 12.4 ± 3.4 103.3 ± 6.0b 






Fig. 1. Mean + SEM effects of increasing concentrations of cilostamide on nuclear maturation 
of peripubertal ovine oocytes following 24 h of culture.  
a,b, w-z
Within a stage of maturation, means without a common superscript differed (P < 0.05).  
GV = germinal vesicle stage, MII = metaphase II.  
 
Fig. 2. Mean + SEM effects of FSK and IBMX on COC cAMP concentrations in peripubertal 
ovine oocytes following 2 h pre-IVM treatments. 
a,b
Means without a common superscript differed (P < 0.05).  
  
Fig. 3. Mean + SEM effects of pre-IVM treatment and cilostamide (CIL) during IVM on the 
nuclear maturation of peripubertal ovine oocytes following 20 h of culture. Pre-IVM: 500 µM 
IBMX + 50 µM forskolin (FSK).  
*Means differed (P < 0.05).  
GV = germinal vesicle stage, AI+TI = anaphase I + telophase I, MII = metaphase II. 
 
Fig. 4. Mean + SD effects of pre-IVM treatment, FSH and cilostamide (CIL) on cAMP 
concentrations in peripubertal ovine COCs following 20 h of culture. Pre-IVM, 500 µM 
IBMX + 100 µM forskolin; FSH, 100 mIU/mL; cilostamide, 1 μM.  
 




Means without a common superscript differed (P < 0.05). 
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